title: Natalizumab treatment in paediatric multiple sclerosis: a case of induction, de-escalation and escalation.
authors: Norman
authors: N
authors: Putzki
authors: Oliver
authors: O
authors: Stich
authors: Kristina
authors: K
authors: Gartzen
authors: Oliver
authors: O
authors: Kastrup
authors: Barbara
authors: B
authors: Tettenborn
authors: Sebastian
authors: S
authors: Rauer
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002648:Child; D004185:Disability Evaluation; D005260:Female; D006801:Humans; D039441:Integrin alpha4 / Q000276:immunology*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab; D012720:Severity of Illness Index
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab; D039441:Integrin alpha4